Published in Volume
101, Issue 6 (March 15, 1998)
J Clin Invest. 1998;101(6):1292–1299.
doi:10.1172/JCI1807.
Copyright ©
1998, The American Society for
Clinical Investigation.
Research Article
Neurological disturbances, premature lethality, and central myelination deficiency in transgenic mice overexpressing the homeo domain transcription factor Oct-6.
N A Jensen, K M Pedersen, J E Celis and M J West
Department of Medical Biochemistry, University of Aarhus, 8000 Aarhus C, Denmark. naj@biobase.dk
Published March 15, 1998
Pit, Oct, Unc (POU) homeo domain transcription factors have been implicated in various developmental processes, including cell division, differentiation, specification, and survival of specific cell types. Although expression of the transcription factor Oct-6 in oligodendroglia is confined to the promyelin stage and is downregulated at the myelin stage of development, the effect of Oct-6 overexpression on oligodendrocyte development has not been established. Here we show that transgenic animals overexpressing Oct-6 at late oligodendrocyte development develop a severe neurologic syndrome characterized by action tremors, recurrent seizures, and premature death. Axons in the central nervous system of Oct-6 transgenics were hypomyelinated, hypermyelinated, or dysmyelinated, and ultrastructural analyses suggested that myelin formation was premature. The vulnerability of developing oligodendroglia to Oct-6 deregulation provides evidence that the POU factor may play a direct role in myelin disease pathogenesis in the mammalian CNS.